POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Enacted

Utah Overhauls Cannabis Regulation, Moving Oversight to Agriculture and Setting Age Verification Rules

Original title: Cannabis Amendments

Last action · March 25, 2026: Governor SignedSponsors: Jen Dailey-Provost and 2 others

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Does

This bill shifts medical cannabis oversight from the Department of Health and Human Services to the Department of Agriculture and Food, requires industrial hemp retailers to verify that purchasers are at least 21 years old, and allows pharmacies to sell s starting May 6, 2026.

Why it matters

Consolidating program administration under the Department of Agriculture and Food changes agency reporting lines for license holders, transfers management of the , and alters compliance standards for hemp retailers and medical cannabis processors across the state.

Background
  • Utah established its medical cannabis program following voter approval of Proposition 2 in 2018, subsequently creating a regulated framework overseen across multiple state agencies. context

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Medical Cannabis Cardholders

Cardholders experience changes in agency administration, transaction fees, and product availability including low THC products at pharmacies.

Directly affected

Industrial Hemp Retailers

Retailers are subject to mandatory age-verification rules for THC cannabinoid products while video surveillance mandates are repealed.

Directly affected

Cannabis Processing Facilities

Processors gain the ability to produce low THC products and are exempt from obtaining separate licenses to process hemp products.

Directly affected

Medical Cannabis Pharmacies

Pharmacies are authorized to sell low THC products and are subject to new transaction fee structures.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Which state agency now oversees the medical cannabis program?
The Department of Agriculture and Food assumes all medical cannabis program duties formerly handled by the Department of Health and Human Services.
What are the new age verification requirements for buying cannabinoid products?
Industrial hemp retailer permittees must check the identification of any customer purchasing a containing THC or a THC analog to ensure they are at least 21 years old.
Can medical cannabis pharmacies sell low THC products under this legislation?
Yes, medical cannabis pharmacies are permitted to sell s produced by licensed cannabis processing facilities.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Current status: Signed into law.

Procedural history

62 actions
  1. Mar 25, 2026Lieutenant Governor's office for filingEnrolled
    Governor Signed
  2. Mar 12, 2026House
    House/ to Governor
  3. Mar 12, 2026House
    House/ received enrolled bill from Printing
  4. Mar 11, 2026House
    House/ enrolled bill to Printing
  5. Mar 11, 2026Clerk of the House
    Enrolled Bill Returned to House or Senate
  6. Mar 6, 2026Legislative Research and General Counsel / Enrolling
    Draft of Enrolled Bill Prepared
Show 56 earlier actions
  1. Mar 6, 2026Legislative Research and General Counsel / Enrolling
    Bill Received from House for Enrolling
  2. Mar 6, 2026House
    House/ signed by Speaker/ sent for enrolling
  3. Mar 6, 2026House
    House/ received from Senate
  4. Mar 6, 2026Senate
    Senate/ to House
  5. Mar 6, 2026Senate
    Senate/ signed by President/ returned to House
  6. Mar 6, 2026Senate
    Senate/ received from House
  7. Mar 5, 2026House
    House/ to Senate
  8. Mar 5, 2026House
    House/ concurs with Senate amendment
  9. Mar 5, 2026House
    House/ placed on Concurrence Calendar
  10. Mar 5, 2026House
    House/ received from Senate
  11. Mar 5, 2026Senate
    Senate/ to House with amendments
  12. Mar 5, 2026SenateFloor
    Senate/ passed 2nd & 3rd readings/ suspension
  13. Mar 5, 2026Senate
    Senate/ substituted
  14. Mar 5, 2026Senate
    Senate/ 2nd & 3rd readings/ suspension
  15. Mar 5, 2026Senate
    Senate/ Rules to 2nd Reading Calendar
  16. Mar 4, 2026Senate
    Senate/ 2nd Reading Calendar to Rules
  17. Mar 4, 2026Released
    LFA/ fiscal note publicly available for HB0389S04
  18. Mar 3, 2026Version Sponsor
    LFA/ fiscal note sent to sponsor for HB0389S04
  19. Feb 27, 2026Legislative Fiscal Agency
    LFA/ bill sent to agencies for fiscal input for HB0389S04
  20. Feb 27, 2026Legislative Fiscal Analyst
    LFA/ bill assigned to staff for fiscal analysis for HB0389S04
  21. Feb 26, 2026Senate
    Senate/ placed on 2nd Reading Calendar
  22. Feb 26, 2026Senate
    Senate/ committee report favorable
  23. Feb 25, 2026Senate
    Senate Comm - Favorable Recommendation
  24. Feb 23, 2026SenateCommittee
    Senate/ to standing committee
  25. Feb 20, 2026Released
    LFA/ fiscal note publicly available for HB0389S03
  26. Feb 20, 2026Version Sponsor
    LFA/ fiscal note sent to sponsor for HB0389S03
  27. Feb 20, 2026SenateIntroduced
    Senate/ 1st reading (Introduced)
  28. Feb 19, 2026Senate
    Senate/ received from House
  29. Feb 19, 2026House
    House/ to Senate
  30. Feb 19, 2026HouseFloor
    House/ passed 3rd reading
  31. Feb 19, 2026House
    House/ substituted
  32. Feb 19, 2026House
    House/ 3rd reading
  33. Feb 18, 2026Legislative Fiscal Agency
    LFA/ bill sent to agencies for fiscal input for HB0389S03
  34. Feb 18, 2026Legislative Fiscal Analyst
    LFA/ bill assigned to staff for fiscal analysis for HB0389S03
  35. Feb 12, 2026Released
    LFA/ fiscal note publicly available for HB0389S02
  36. Feb 12, 2026Version Sponsor
    LFA/ fiscal note sent to sponsor for HB0389S02
  37. Feb 12, 2026House
    House/ 2nd reading
  38. Feb 12, 2026House
    House/ comm rpt/ substituted
  39. Feb 11, 2026House
    House Comm - Favorable Recommendation
  40. Feb 11, 2026House
    House Comm - Substitute Recommendation
  41. Feb 11, 2026Legislative Fiscal Agency
    LFA/ bill sent to agencies for fiscal input for HB0389S02
  42. Feb 11, 2026Legislative Fiscal Analyst
    LFA/ bill assigned to staff for fiscal analysis for HB0389S02
  43. Feb 6, 2026HouseCommittee
    House/ to standing committee
  44. Feb 5, 2026Released
    LFA/ fiscal note publicly available for HB0389S01
  45. Feb 5, 2026Version Sponsor
    LFA/ fiscal note sent to sponsor for HB0389S01
  46. Feb 3, 2026House
    House/ received fiscal note from Fiscal Analyst
  47. Feb 3, 2026Released
    LFA/ fiscal note publicly available for HB0389
  48. Feb 2, 2026Legislative Fiscal Agency
    LFA/ bill sent to agencies for fiscal input for HB0389S01
  49. Feb 2, 2026Legislative Fiscal Analyst
    LFA/ bill assigned to staff for fiscal analysis for HB0389S01
  50. Jan 29, 2026Version Sponsor
    LFA/ fiscal note sent to sponsor for HB0389
  51. Jan 27, 2026HouseIntroduced
    House/ 1st reading (Introduced)
  52. Jan 27, 2026House
    House/ received bill from Legislative Research
  53. Jan 26, 2026Legislative Fiscal Agency
    LFA/ bill sent to agencies for fiscal input for HB0389
  54. Jan 26, 2026Legislative Fiscal Analyst
    LFA/ bill assigned to staff for fiscal analysis for HB0389
  55. Jan 26, 2026Legislative Research and General Counsel
    Numbered Bill Publicly Distributed
  56. Jan 26, 2026Legislative Research and General Counsel
    Bill Numbered but not Distributed

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift99% confidence

Consolidation of Cannabis Oversight

The state consolidated all medical cannabis program responsibilities under the Department of Agriculture and Food, removing them from the Department of Health and Human Services.

Connected Entities

Qualified Patient Enterprise Fund, Department of Agriculture and Food, Evan J. Vickers and 4 more
OrganizationQualified Patient Enterprise Fund“Enterprise fund whose control is moved to the Department of Agriculture and Food”Map →
OrganizationDepartment of Agriculture and Food“State agency assuming medical cannabis program duties”Map →
PersonEvan J. Vickers“Senate Sponsor”Map →
PersonJennifer Dailey-Provost“Chief Sponsor in the lower house”Map →
OrganizationCenter for Medical Cannabis Research“Research entity receiving funds from the enterprise fund”Map →
OrganizationSpecialized Product Authority Licensing Board“Renamed licensing board supervising cannabis and hemp establishments”Map →
OrganizationDepartment of Health and Human Services“State agency previously exercising medical cannabis duties transferred by the bi”Map →

Sources

Analysis Score

0–100
  • Significance80
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz35
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record